The drug of choice for managing hyperglycemia in diabetic ketoacidosis is:
**Core Concept**
The management of diabetic ketoacidosis (DKA) involves correcting hyperglycemia, metabolic acidosis, and fluid deficits. **Insulin therapy** is crucial in this setting. The choice of insulin and its mode of administration are critical for effective management.
**Why the Correct Answer is Right**
The correct answer is typically **insulin**, specifically **regular insulin** administered intravenously. This is because insulin is essential for glucose uptake by cells, thereby reducing blood glucose levels. In DKA, the body has a significant deficiency of insulin, either due to an absolute lack of insulin (Type 1 diabetes) or insulin resistance (Type 2 diabetes).
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while it might be a treatment for diabetes, it's not specified and thus can't be the best choice.
**Option B:** Incorrect as it doesn't directly address hyperglycemia in DKA.
**Option C:** Incorrect because, although it might be related to diabetes management, it's not the primary treatment for hyperglycemia in DKA.
**Option D:** Incorrect as it's not the standard first-line treatment for hyperglycemia in DKA.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **intravenous regular insulin** is preferred in DKA due to its rapid onset and short duration of action, allowing for precise control of blood glucose levels.
**Correct Answer:** D. Regular insulin.